Acessibilidade / Reportar erro

Decrease in prevalence of Helicobacter pylori infection during a 10-year period in Brazilian children

Diminuição na prevalência da infecção por Helicobacter pylori em crianças brasileiras num período de 10 anos

Abstracts

BACKGROUND: Decreasing prevalence of H pylori infection has been reported in some countries. AIM: To evaluate the prevalence of Helicobacter pylori infection in a 10-year period in children submitted to upper digestive endoscopy. METHODS: It was a retrospective observational study. The records of 1,165 endoscopies performed during a 10-year period in a public hospital of the City of São Paulo, SP, Brazil, in patients up to 18-year-old. Only the first endoscopy was considered. Helicobacter pylori infection was defined by the rapid urease test, performed with one fragment of antral mucosa. Chi-square for trend has been estimated to compare Helicobacter pylori prevalence across the period. RESULTS: The main indication for endoscopy was epigastric pain (47.4%). There were 392 patients with H pylori infection (33.6%), 12.8% being infants, 19.4% toddlers, 28.8% schoolchildren and 46.3% adolescents. Prevalence was 60.47% in the first year of the study and 30.43% in the last. Among the less than 6-year-old patients there was a decrease in infection prevalence from 25% for the 1993-6 period to 14.3% in the 2000-02 period, while among the over 12-year-old patients the decrease was from 55.5% in the first period to 39.6% in the latter. The decrease in H pylori infection prevalence was more intense within patients with epigastric pain, in which prevalence has decreased from 48.2% (92/191) in 1993-6, to 41.9% (65/155) in 1997-9 and 27.7% (57/206) in 2000-02. CONCLUSION: The study suggests a significant decrease in the prevalence of H pylori infection regarding the studied patients. The trend was mainly observed in the younger age group and in patients with epigastric pain.

Helicobacter infection; Urease; Child


RACIONAL: Redução da prevalência de infecção por Helicobacter pylori tem sido relatada em alguns países. OBJETIVO: Avaliar, em crianças, a prevalência de infecção por H pylori em um período de 10 anos, realizando endoscopia digestiva alta. MÉTODOS: Estudo retrospectivo observacional. Os relatórios de 1.165 endoscopias digestivas altas realizadas em 10 anos em um hospital público da cidade de São Paulo, SP, foram revisados, sendo incluídas as primeiras endoscopias de pacientes com idade inferior a 18 anos. A infecção por H pylori foi definida pelo teste rápido da urease, com um fragmento de mucosa antral. RESULTADOS: A principal indicação de endoscopia foi dor epigástrica (47,4%). A prevalência de infecção foi 33,6% (12,8% em lactentes, 19,4% em pré-escolares, 28,8% em escolares e 46,3% em adolescentes). No primeiro ano de estudo foi 60,47%, e 30,43% no último. Entre os pacientes menores de 6 anos, houve diminuição na prevalência de 25% (1993-6) para 14.3% (2000-02), enquanto entre os pacientes maiores de 12 anos a diminuição foi de 55,5% (1993-6) para 39,6% (2000-02). A diminuição da prevalência foi significativa nos pacientes com dor epigástrica, nos quais passou de 48,2% (92/191) em 1993-6, para 41,9% (65/155) em 1997-9 e 27,7% (57/206) em 2000-02. CONCLUSÃO: O estudo sugere que houve diminuição significativa na prevalência da infecção por H pylori nos pacientes estudados. A tendência foi principalmente observada no grupo etário mais jovem e nos pacientes com dor epigástrica.

Infecções por Helicobacter; Urease; Criança


GASTROENTEROLOGIA PEDIÁTRICA PEDIATRIC GASTROENTEROLOGY

Decrease in prevalence of Helicobacter pylori infection during a 10-year period in Brazilian children

Diminuição na prevalência da infecção por Helicobacter pylori em crianças brasileiras num período de 10 anos

Elisabete Kawakami; Rodrigo Strehl Machado; Silvio Kazuo Ogata; Marini Langner

"Universidade Federal de São Paulo / Escola Paulista de Medicina" , São Paulo, SP, Brazil

Corrrespondence

ABSTRACT

BACKGROUND: Decreasing prevalence of H pylori infection has been reported in some countries.

AIM: To evaluate the prevalence of Helicobacter pylori infection in a 10-year period in children submitted to upper digestive endoscopy.

METHODS: It was a retrospective observational study. The records of 1,165 endoscopies performed during a 10-year period in a public hospital of the City of São Paulo, SP, Brazil, in patients up to 18-year-old. Only the first endoscopy was considered. Helicobacter pylori infection was defined by the rapid urease test, performed with one fragment of antral mucosa. Chi-square for trend has been estimated to compare Helicobacter pylori prevalence across the period.

RESULTS: The main indication for endoscopy was epigastric pain (47.4%). There were 392 patients with H pylori infection (33.6%), 12.8% being infants, 19.4% toddlers, 28.8% schoolchildren and 46.3% adolescents. Prevalence was 60.47% in the first year of the study and 30.43% in the last. Among the less than 6-year-old patients there was a decrease in infection prevalence from 25% for the 1993-6 period to 14.3% in the 2000-02 period, while among the over 12-year-old patients the decrease was from 55.5% in the first period to 39.6% in the latter. The decrease in H pylori infection prevalence was more intense within patients with epigastric pain, in which prevalence has decreased from 48.2% (92/191) in 1993-6, to 41.9% (65/155) in 1997-9 and 27.7% (57/206) in 2000-02.

CONCLUSION: The study suggests a significant decrease in the prevalence of H pylori infection regarding the studied patients. The trend was mainly observed in the younger age group and in patients with epigastric pain.

Headings: Helicobacter infection, epidemiology. Urease. Child.

RESUMO

RACIONAL: Redução da prevalência de infecção por Helicobacter pylori tem sido relatada em alguns países.

OBJETIVO: Avaliar, em crianças, a prevalência de infecção por H pylori em um período de 10 anos, realizando endoscopia digestiva alta.

MÉTODOS: Estudo retrospectivo observacional. Os relatórios de 1.165 endoscopias digestivas altas realizadas em 10 anos em um hospital público da cidade de São Paulo, SP, foram revisados, sendo incluídas as primeiras endoscopias de pacientes com idade inferior a 18 anos. A infecção por H pylori foi definida pelo teste rápido da urease, com um fragmento de mucosa antral.

RESULTADOS: A principal indicação de endoscopia foi dor epigástrica (47,4%). A prevalência de infecção foi 33,6% (12,8% em lactentes, 19,4% em pré-escolares, 28,8% em escolares e 46,3% em adolescentes). No primeiro ano de estudo foi 60,47%, e 30,43% no último. Entre os pacientes menores de 6 anos, houve diminuição na prevalência de 25% (1993-6) para 14.3% (2000-02), enquanto entre os pacientes maiores de 12 anos a diminuição foi de 55,5% (1993-6) para 39,6% (2000-02). A diminuição da prevalência foi significativa nos pacientes com dor epigástrica, nos quais passou de 48,2% (92/191) em 1993-6, para 41,9% (65/155) em 1997-9 e 27,7% (57/206) em 2000-02.

CONCLUSÃO: O estudo sugere que houve diminuição significativa na prevalência da infecção por H pylori nos pacientes estudados. A tendência foi principalmente observada no grupo etário mais jovem e nos pacientes com dor epigástrica.

Descritores: Infecções por Helicobacter, epidemiologia. Urease. Criança.

INTRODUCTION

Adult individuals who live in precarious conditions during childhood constitute the population at the highest risk for morbidity due to Helicobacter pylori infection. The recent increase in life expectancy in most of these countries allows foreseeing an increase of its morbidity in the next years, particularly due to peptic ulcers and gastric cancer.

Study of the epidemiology of H pylori infection in childhood allows to visualize morbidity in adult life, since it is at this age that most patients acquire the infection, even in developed countries(18). On the other hand, incidence in childhood is related to prevalence in adults, since the child is more exposed to the bacterium by contagion within the family, particularly the infected mother(4). Presently it is believed that the infection is acquired during childhood, mainly in populations at high risk. Studies show a 2.2%-3.3% incidence among children of developing countries or groups at high risk in developed countries(7, 9, 11), although most of these studies are based on serology, a test of less accuracy in smaller children(2, 15).

In developed countries, the past high prevalence of the infection was surpassed by improvement in environmental conditions, since its prevalence is closely related to socioeconomic factors. Some recent studies suggest that infection incidence in high-risk groups in developed countries, particularly immigrants, is declining, similarly to developing countries, as a consequence of better access to health, unintentional use of medications (antibiotics and antisecretory drugs) and improvement in environmental conditions(13, 17, 20).

In our country, documented improvement of infantile mortality and increase in life expectancy occurred in the last decades, attributed to improvement in basic sanitation and access to the public health system(10). We may experience a silent decrease in the prevalence of H pylori infection.

The objective of this study was to verify differences in H pylori infection based on a retrospective analysis of a data bank of an endoscopy service of a public university hospital in the city of São Paulo, Brazil.

METHODS

A retrospective study where the records of upper digestive endoscopy performed from 1993 to 2002 at the Digestive Endoscopy Sector of the Pediatric Gastroenterology Division, " Universidade Federal de São Paulo – Escola Paulista de Medicina" – UNIFESP/EPM, São Paulo, SP, Brazil, were reviewed. The attended patients are from the public health system, generally from low-income families, referred from Health Units or from the outpatient clinic of Pediatric Gastroenterology, UNIFESP/EPM. Records of 2003 to 2004 were not included because in those years part of the services were transferred to other sectors.

Patients

Only the first upper digestive endoscopies of less than 20-year-old patients performed in the studied period using the rapid urease test were analyzed (Figure 1). One thousand one hundred sixty-five patients, aged from 1 month to 19 years and 8 months were included (M/F 563:602, mean 8.82 years, standard deviation 4.31 years). These cases originated from several research protocols on diagnosis and treatment of infection with H pylori during the studied decade. Usually the rapid urease breath test was performed in all patients, except for those in use of antibiotics, antisecretory drugs or bismuth salts in the last months for non-digestive diseases and with a therapeutic purpose.


Endoscopy

It was performed after an 8-hour fast under conscious sedation with midazolam and meperidine (over 10-year-old patients) or under deep sedation administered by an anesthetist (the other patients).

Rapid urease test (RUT)

A non-commercial solution, prepared in the endoscopy room was used. This solution contains 100 mg urea in 1 mL distilled water, with a drop of phenol red. RUT is evaluated within 1 hour after immersion of two gastric antrum fragments, and was previously validated in our service, with 100% sensitivity and 84.2% specificity(12).

Statistics

The quantitative variables were summarized by estimation of mean and standard deviation, while the qualitative by proportion. Pearson's chi-square test was used for comparison between treatment groups in 2x2 tables. Significance of trend to variation of positive results for RUT was evaluated by chi-square for trend, with a significance level of 0.05(1).

RESULTS

In the studied period most indication for endoscopy of the 1,165 cases was epigastric pain with 47.4%, followed by gastroesophageal reflux with 16.5% (Table 1). Indication for the test presented a significant variation during the period, significant trend to lower proportion of patients with epigastric pain and higher proportion of patients with malabsorption syndrome in the series of the more recent years (Table 2).

There was a higher proportion of patients less than 6 years old in the more recent years (16.3% in 1993, 36.6% in 2002, χ2trend = 33.68, P = 0.0001). Correspondently there was a significant decrease in the proportion of patients with age equal to or more than 12 years (27.9% in 1933, 15.5% in 2002, χ2trend = 11.97, P = 0.0005), as well as patients with age between 6 years and 12 years (55.8% in 1993, 47.8% in 2002, χ2trend = 4.76, P = 0.0291).

General prevalence of H pylori infection was 33.6% (392/1165) in the studied period. There was no difference between male and female gender regarding prevalence (216/602F and 176/563M, P = 0.107), except for over 12-year-old patients, where a higher infection prevalence occurred in females (58.5%, vs 39.8%, P = 0.002). Infection was significantly associated with the endoscopic diagnoses of duodenal ulcer and nodular antrum gastritis, and inversely associated with a normal examination (Table 3). A direct and significant relationship between prevalence and the patient's age was observed, with 12.8% (11/86) infected among those less than 2 years old, 19.4% (46/273) among preschool children, 28.8% (90/313) among patients with age between 6 and 10 years and 46.3% (245/529) among the patients over ten years old (χ2trend = 165.69, P = 0.0001).

During the studied period there occurred significant prevalence of infection reduction from 39.1% in the 1993-1994 biennium to 28.4% in the 2001-2002 biennium (Figure 2, χ2trend = 14.84, P = 0.0001). In the analysis according to age range, the interval was divided into three periods (1993-6, 1997-9, 2000-2). Among the patients with age less than 6 years, there was a reduction in prevalence from 25% (18/72) in the first period to 19.3% (12/62) in the second period and finally 14.3% (27/189) in the last period (χ2trend = 4.27, P = 0.038). In the patients aged 12 years or more the percents were respectively 55.5% (61/110), 57.3% (47/82) and 39.6% (42/106) (χ2trend = 5.34, P = 0.021). In the intermediary age range infection prevalence did not present variation (37.1%, 31.6% and 32.9%, χ2trend = 0.75, P = 0.386) (Figure 3).



The decrease in H pylori infection prevalence was more intense within patients with epigastric pain, in which prevalence has decreased from 48.2% (92/191) in 1993-6, to 41.9% (65/155) in 1997-9 and 27.7% (57/206) in 2000-02 (χ2trend = 17.66, P = 0.00003), but it was not significant in patients with malabsorption, in which prevalence was 28% (7/25) in 1993-6, to 29.4% (5/17) in 1997-9 and 19.8% (23/116) in 2000-02 (χ2trend = 1.125, P = 0.29).

DISCUSSION

The study showed decrease in H pylori prevalence during a 10-year period, with a 39.1% reduction in the 1993 to 1994 biennium to 28.4% in the 2003-2004 biennium. Despite the increase during the period in the number of examinations performed in younger patients, we could show that decrease in prevalence was significant in two age ranges: less than 6-year-old patients and adolescents. A more detailed analysis of the variation according to age range is difficult because of the small number of patients. However, reduction in infection prevalence in children less than 6 years old constitutes a strong evidence of the current change in the epidemiology among us. Recently, ROWLAND et al.(18) evaluated prospectively the incidence of H pylori infection during 4 consecutive years using the 13C-urea breath test in 227 Irish children aged 2 to 4 years. The authors observed that infection rate for 100 individuals/year was higher between 2 and 3 years (5.05; CI 95%: 1.64-11.78); 47/48 infected children acquired the infection before the age of 5 years and only one, after the age of 5. This study shows that even in a developed country, the first infection occurred early. In Germany, in children of Turkish descent, incidence in those less than 4 years old was 7%, being higher during the second year of life(16). The importance of childhood in the epidemiology of the infection is similar in the different situations and not dependent on the socioeconomic condition(19).

Retrospective evaluation imposes restrictions: population-based prospective design is undoubtedly more consistent for the study of the epidemiology of the pathogen in a historical series. However, the different research protocols of H pylori infection in children in the studied period led to the natural exclusion of patients where the urease test was less accurate, since routinely the patient or representative is asked about medications in use. Finally, inclusion of only the first endoscopy performed in the service contributes to a greater safety regarding quality of data.

In the study only 63.1% of the patients with duodenal ulcer had a positive urease test. This figure is surprising, since we recently reported a series of duodenal ulcer cases with 95.3% of the patients with H pylori(5). However, other ulcer cases have to be taken into account, such as use of anti-inflammatory drugs and non-H pylori related ulcer disease(3).

Change in the profile of patients who attend the service may be reflected in the found result. The " Hospital São Paulo" linked to UNIFESP/EPM attends patient of the Public Health System and of private health insurance companies. However, the studied data base included only patients from the Public Health System, since the data bank does not encompass patients of the private health insurance companies. During the period there was no alteration in the reference system and the patients were usually referred by the Pediatric Gastroenterology outpatient clinic of the institution. Thus, we think that alterations in the attended socioeconomic profile would only reflect alterations in the socioeconomic profile of the population as a whole, without relation to access to the health service. From 2003 on there were changes in agenda organization criteria, which was the reason for excluding the years of 2003 and 2004 from the analysis. Clinical features of patients have changed during the study period, and the change has attenuated the decrease of H pylori prevalence. There was a decline of proportion of patients with epigastric pain, but the decline of prevalence in these patients was sharper than in the whole group. On the other hand, it has been increased proportion of endoscopies to evaluate malabsorption. This group of patients has not varied the infection prevalence, which was already low since the beginning of the period. It is common in our country treat patients with failure to thrive with anti-parasite medicines before further evaluation, and metronidazol is a very popular drug in this context.

Reduction in the prevalence of H pylori gastritis and its consequences is a phenomenon recognized in developed countries, where the analysis of historical series allows foreseeing the natural eradication of the infection in the next centuries(19). In Holland, a retrospective study of 14,909 endoscopies performed during 10 years (1993 to 2002) showed a trend towards decrease in infection prevalence in patients less than 50 years old, pointing to a lower than 10% prevalence in this age group in 2009 and global prevalence less than 10% in 2027(8). In Spain there was a reduction in prevalence from 1990 to 2000 (adults) among users of an endoscopy service from 76.3% to 69.3% with a parallel decrease in duodenal ulcer incidence (130.8 per 100,000 inhabitants in 1985 to 86.1 in 2000) and its complications (109.1 per 100,000 inhabitants in 1990 to 81.4 in 2000)(14). In the period, in spite of the slight increase in anti-inflammatory drug use, there was a great increase in the prescription of proton pump inhibitors. Even in high prevalence population groups in developed countries, the infection is on the decline, particularly in childhood. In only one year, a group identified a 9% to 4% prevalence decrease in children of Turkish immigrants in Germany, in their first year of life(17). In developing countries there is already increasing evidence of decrease in prevalence of infection and its consequences. In Estonia, adjusted seroprevalence of infection among hospitalized children decreased from 42.2% to 28.1% in 1991 to 2002, with a more intense decrease in the group aged less than 5 years(13). In the Philippines, from 1996 to 2002 there was a reduction of duodenal ulcer prevalence from 15.83% to 7.02% in adults, from 20.05% to 14.7% for gastric ulcer among patients with endoscopy while, among patients with peptic ulcer the proportion of infected patients decreased from 71.9% to 34.6%(20). A study from Hong Kong reached similar results, but with the additional factor of less consumption of anti-inflammatory drugs in the period(21). A seroprevalence study in Taiwan did not reproduce the trend on comparing its data with another study of 1989. However, the study was conducted with a population of low infection prevalence (0.9% between 1 and 3 years of age to 19.4%, between 9 and 12 years, in 1989) and the two studies used different serology tests(6).

The present study detected reduction in the prevalence of H pylori infection in an endoscopy data bank of patients attended at a public hospital in the city of São Paulo, particularly those at a higher risk to acquire the infection. Prospective studies on the epidemiology of the infection among us are needed to better establish goals to fight it.

Correspondence:

Dr. Rodrigo Strehl Machado

Pediatric Gastroenterology Division

Rua Pedro de Toledo, 441

04039-031 – São Paulo, SP, Brazil

E-mail: rodrigo@gastroped.epm.br

Recebido em 10/5/2007.

Aprovado em 17/10/2007.

This study was conducted on Pediatric Gastroenterology Division of " Universidade Federal de São Paulo

  • 1. Altman DG. Practical statistics for medical research. London: Chapman & Hall; 1991.
  • 2. de Oliveira AM, Rocha GA, Queiroz DM, Mendes EN, de Carvalho AS, Ferrari TC, Nogueira AM. Evaluation of enzyme-linked immunosorbent assay for the diagnosis of Helicobacter pylori infection in children from different age groups with and without duodenal ulcer. J Pediatr Gastroenterol Nutr. 1999;28:157-61.
  • 3. Elitsur Y, Lawrence Z. Non-Helicobacter pylori related duodenal ulcer disease in children. Helicobacter. 2001;6:239-43.
  • 4. Escobar ML, Kawakami E. Evidence of mother-child transmission of Helicobacter pylori infection. Arq Gastroenterol. 2004;41:239-44.
  • 5. Kawakami E, Machado RS, Fonseca JA, Patricio FR. [Clinical and histological features of duodenal ulcer in children and adolescents.] J Pediatr (Rio J). 2004;80:321-5.
  • 6. Lee IH, Ni YH, Chang MH. Stable seroprevalence of Helicobacter pylori infection in children during 1989-1999 in Taipei, Taiwan. Pediatr Int. 2004;46:311-4.
  • 7. Lindkvist P, Asrat D, Nilsson I, Tsega E, Olsson GL, Wretlind B, Giesecke J. Age at acquisition of Helicobacter pylori infection: comparison of a high and a low prevalence country. Scand J Infect Dis. 1996;28:181-4.
  • 8. Loffeld RJ, van der Putten AB. Changes in prevalence of Helicobacter pylori infection in two groups of patients undergoing endoscopy and living in the same region in the Netherlands. Scand J Gastroenterol. 2003;38:938-41.
  • 9. Malaty HM, El-Kasabany A, Graham DY, Miller CC, Reddy SG, Srinivasan SR, Yamaoka Y, Berenson GS. Age at acquisition of Helicobacter pylori infection: a follow-up study from infancy to adulthood. Lancet. 2002;359:931-5.
  • 10. Monteiro CA, Nazario CL. Evolução de condicionantes ambientais da saúde na infância na cidade de São Paulo (1984-1996). Rev Saude Publica. 2000;34(6 Suppl):s13-8.
  • 11. Naficy AB, Frenck RW, Abu-Elyazeed R, Kim Y, Rao MR, Savarino SJ, Wierzba TF, Hall E, Clemens JD. Seroepidemiology of Helicobacter pylori infection in a population of Egyptian children. Int J Epidemiol. 2000;29:928-32.
  • 12. Ogata SK, Kawakami E, Patricio FR, Pedroso MZ, Santos AM. Evaluation of invasive and non-invasive methods for the diagnosis of Helicobacter pylori infection in symptomatic children and adolescents. São Paulo Med J. 2001;119:67-71.
  • 13. Oona M, Utt M, Nilsson I, Uibo O, Vorobjova T, Maaroos HI. Helicobacter pylori infection in children in Estonia: decreasing seroprevalence during the 11-year period of profound socioeconomic changes. Helicobacter. 2004;9:233-41.
  • 14. Perez-Aisa MA, Del Pino D, Siles M, Lanas A. Clinical trends in ulcer diagnosis in a population with high prevalence of Helicobacter pylori infection. Aliment Pharmacol Ther. 2005;21:65-72.
  • 15. Portorreal A, Kawakami E. Evaluation of enzyme-linked immunosorbent assay for the diagnosis of Helicobacter pylori infection in children and adolescents. Arq Gastroenterol. 2002;39:198-203.
  • 16. Rothenbacher D, Bode G, Brenner H. Dynamics of Helicobacter pylori infection in early childhood in a high-risk group living in Germany: loss of infection higher than acquisition. Aliment Pharmacol Ther. 2002;16:1663-8.
  • 17. Rothenbacher D, Schultze V, Jahnig P, Scharschmidt B, Brenner H. Evidence of a rapid decrease in prevalence of Helicobacter pylori infection in children of a high risk group living in Germany. Eur J Pediatr. 2004;163:339-40.
  • 18. Rowland M, Daly L, Vaughan M, Higgins A, Bourke B, Drumm B. Age-specific incidence of Helicobacter pylori Gastroenterology. 2006;130:65-72.
  • 19. Rupnow MF, Shachter RD, Owens DK, Parsonnet J. A dynamic transmission model for predicting trends in Helicobacter pylori and associated diseases in the United States. Emerg Infect Dis. 2000;6:228-37.
  • 20. Wong SN, Sollano JD, Chan MM, Carpio RE, Tady CS, Ismael AE, Judan-Ruiz EA, Ang VN, Go JT, Lim VY, Perez JY, Alvarez SZ. Changing trends in peptic ulcer prevalence in a tertiary care setting in the Philippines: a seven-year study. J Gastroenterol Hepatol. 2005;20:628-32.
  • 21. Xia B, Xia HH, Ma CW, Wong KW, Fung FM, Hui CK, Chan CK, Chan AO, Lai KC, Yuen MF, Wong BC. Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong Kong. Aliment Pharmacol Ther. 2005;22:243-9.

Publication Dates

  • Publication in this collection
    07 July 2008
  • Date of issue
    June 2008

History

  • Received
    10 May 2007
  • Accepted
    17 Oct 2007
Instituto Brasileiro de Estudos e Pesquisas de Gastroenterologia e Outras Especialidades - IBEPEGE. Rua Dr. Seng, 320, 01331-020 São Paulo - SP Brasil, Tel./Fax: +55 11 3147-6227 - São Paulo - SP - Brazil
E-mail: secretariaarqgastr@hospitaligesp.com.br